# TARGETed Therapy Drug MONITOring in DIGestive Oncology

> **NCT05443087** · NA · RECRUITING · sponsor: **UNICANCER** · enrollment: 330 (estimated)

## Conditions studied

- Digestive Cancer
- Metastatic Colorectal Cancer
- Hepatocellular Carcinoma
- GIST
- Neuroendocrine Tumors

## Interventions

- **OTHER:** Blood sampling to build population pharmacokinetics model

## Key facts

- **NCT ID:** NCT05443087
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-29
- **Primary completion:** 2026-08
- **Final completion:** 2027-06
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05443087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05443087, "TARGETed Therapy Drug MONITOring in DIGestive Oncology". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05443087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*